TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Recipharm Uppsala AB
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
666,790
|
469,590
|
378,887 |
Financial expenses |
8,510
|
1,153
|
285 |
Earnings before taxes |
142,187
|
2,990
|
1,823 |
EBITDA |
159,054
|
16,529
|
14,398 |
Total assets |
362,477
|
314,878
|
258,578 |
Current assets |
245,678
|
235,581
|
186,434 |
Current liabilities |
299,601
|
256,362
|
205,551 |
Equity capital |
39,730
|
42,830
|
44,345 |
- share capital |
1,013
|
946
|
975 |
Employees (average) |
196
|
197
|
198 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
11.0%
|
13.6%
|
17.1% |
Turnover per employee |
3,402
|
2,384
|
1,914 |
Profit as a percentage of turnover |
21.3%
|
0.6%
|
0.5% |
Return on assets (ROA) |
41.6%
|
1.3%
|
0.8% |
Current ratio |
82.0%
|
91.9%
|
90.7% |
Return on equity (ROE) |
357.9%
|
7.0%
|
4.1% |
Change turnover |
163,879
|
102,090
|
43,251 |
Change turnover % |
33%
|
28%
|
13% |
Chg. No. of employees |
-1
![]() |
-1
|
-6 |
Chg. No. of employees % |
-1%
![]() |
-1%
|
-3% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.